Correction: Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.
- DOI
- 10.1186/s12943-026-02777-5
- Published
- 2026 Sep 4
- Container
- Molecular cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-026-02777-5,
title = {Correction: Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.},
author = {Zeng F and Guo J and Zeng Z and Zhang VX and Tsui YM and Li PM and Husain A and Zhang Q and Lee JM and Cheung TT and Ho DW and Ng IO},
year = {2026},
journal = {Molecular cancer},
doi = {10.1186/s12943-026-02777-5},
url = {https://doi.org/10.1186/s12943-026-02777-5}
}RIS
TY - JOUR TI - Correction: Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma. AU - Zeng F AU - Guo J AU - Zeng Z AU - Zhang VX AU - Tsui YM AU - Li PM AU - Husain A AU - Zhang Q AU - Lee JM AU - Cheung TT AU - Ho DW AU - Ng IO PY - 2026 JO - Molecular cancer DO - 10.1186/s12943-026-02777-5 UR - https://doi.org/10.1186/s12943-026-02777-5 ER -
APA
F, Z., J, G., Z, Z., VX, Z., YM, T., PM, L., A, H., Q, Z., JM, L., TT, C., DW, H., & IO, N. (2026). Correction: Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.. Molecular cancer. https://doi.org/10.1186/s12943-026-02777-5
Source records
- pubmed · retrieved 2026-09-25T20:32:04.280Z